Business Context and Reporting Period
This Form 8-K was filed by Sunshine Heart, Inc. on March 21, 2014. The filing reports the entry into a material definitive agreement to establish an at-the-market equity offering program. Note: The request metadata references "Nuwellis, Inc.," but the filing text explicitly identifies the registrant as Sunshine Heart, Inc.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial metric disclosed is the authorization of an equity offering with an aggregate offering price of up to $40 million.
Material Changes and Agreements
- At-the-Market Sales Agreement: On March 21, 2014, the Company entered into a Sales Agreement with Cowen and Company, LLC.
- Offering Structure: The Company may issue and sell shares of common stock ($0.0001 par value) through Cowen, acting as agent and/or principal, in transactions deemed "at the market offerings" under Rule 415 of the Securities Act.
- Flexibility: The Company has no obligation to sell any shares and may suspend or terminate the agreement at any time upon written notice.
Costs, Risks, and Management Commentary
- Compensation: The Company will pay Cowen a commission of up to 3.0% of the gross proceeds from the sale of shares.
- Expenses: The Company is responsible for expenses incident to the agreement, including legal fees for Cowen's counsel, capped at $50,000.
- Indemnification: The Company agreed to indemnify and provide contribution to Cowen against certain liabilities, including those under the Securities Act.
- Risk Factors: The filing notes that no sale of shares will occur in any state where such sale would be unlawful prior to registration or qualification.
Investor Verification Checklist
- Verify the current share price and market capitalization to assess the potential dilution impact of a $40 million offering.
- Review the full text of the Sales Agreement (Exhibit 10.1) for specific termination clauses and pricing mechanisms.
- Confirm the Company's current cash position and liquidity needs to understand the urgency of this financing program.
- Check subsequent filings to determine if shares have actually been sold under this agreement and the total proceeds raised.